The heterogeneous allelic repertoire of human toll-like receptor (TLR) genes

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Georgel, Philippe ^a   Macquin, Cécile ^a   Bahram, Seiamak ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HÔPITAL CIVIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; DNA; LIGAND; OLIGONUCLEOTIDE;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; IMMUNE DEFICIENCY; INNATE IMMUNITY; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BIOLOGICAL MODEL; COHORT ANALYSIS; DIMERIZATION; DNA SEQUENCE; GENETIC VARIABILITY; GENETICS; METABOLISM; MOLECULAR CLONING; POLYMERASE CHAIN REACTION;

VERTEBRATA;

ALLELES; CLONING, MOLECULAR; COHORT STUDIES; DIMERIZATION; DNA; GENE FREQUENCY; GENETIC VARIATION; HUMANS; LIGANDS; MODELS, GENETIC; OLIGONUCLEOTIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TOLL-LIKE RECEPTORS;

EID: 70849111218     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007803     Document Type: Article

References (52)

1. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA (1996) The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973-983.
2. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
3. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, et al. (2006) Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 24: 353-389.
4. Beutler B (2009) Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 227: 248-263.
5. Werling D, Jann OC, Offord V, Glass EJ, Coffey TJ (2009) Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol 30: 124-130.
6. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17: 1-14.
7. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, et al. (2005) CD36 is a sensor of diacylglycerides. Nature 433: 523-527.
8. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, et al. (2005) CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6: 565-570.
9. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191.
10. Schroder NW, Schumann RR (2005) Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5: 156-164.
11. Bochud PY, Bochud M, Telenti A, Calandra T (2007) Innate immunogenetics: a tool for exploring new frontiers of host defence. Lancet Infect Dis 7: 531-542.
12. Smirnova I, Mann N, Dols A, Derkx HH, Hibberd ML, et al. (2003) Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci U S A 100: 6075-6080.
13. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA (2000) A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68: 6398-6401.
14. Pirie FJ, Pegoraro R, Motala AA, Rauff S, Rom L, et al. (2005) Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Tissue Antigens 66: 125-130.
15. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, et al. (2003) A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 198: 1563-1572.
16. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, et al. (2003) Activation of autoreactive B cells by CpG dsDNA. Immunity 19: 837-847.
17. Robinson J, Waller MJ, Fail SC, McWilliam H, Lopez R, et al. (2009) The IMGT/HLA database. Nucleic Acids Res 37: D1013-1017.
18. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, et al. (2002) Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169: 10-14.
19. Sun J, Wiklund F, Zheng SL, Chang B, Balter K, et al. (2005) Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst 97: 525-532.
20. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, et al. (2007) Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178: 7520-7524.
21. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, et al. (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130: 1071-1082.
22. Eid AJ, Brown RA, Paya CV, Razonable RR (2007) Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation 84: 511-516.
23. Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR (2007) Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 44: 1315-1320.
24. Merx S, Neumaier M, Wagner H, Kirschning CJ, Ahmad-Nejad P (2007) Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene. Hum Mol Genet 16: 1225-1232.
25. Texereau J, Chiche JD, Taylor W, Choukroun G, Comba B, et al. (2005) The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis 41 Suppl 7: S408-415.
26. Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA (2008) The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 59: 343-359.
27. Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, et al. (2005) Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc Natl Acad Sci U S A 102: 2487-2489.
28. Smirnova I, Poltorak A, Chan EK, McBride C, Beutler B (2000) Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol 1: RESEARCH002.
29. Smirnova I, Hamblin MT, McBride C, Beutler B, Di Rienzo A (2001) Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics 158: 1657-1664.
30. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, et al. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103.
31. Henneke P, Morath S, Uematsu S, Weichert S, Pfitzenmaier M, et al. (2005) Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol 174: 6449-6455.
32. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, et al. (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A 97: 13766-13771.
33. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, et al. (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3: 196-200.
34. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, et al. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529.
35. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
36. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
37. Bochud PY, Hersberger M, Taffe P, Bochud M, Stein CM, et al. (2007) Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 21: 441-446.
38. Mockenhaupt FP, Hamann L, von Gaertner C, Bedu-Addo G, von Kleinsorgen C, et al. (2006) Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J Infect Dis 194: 184-188.
39. De Jager PL, Richardson A, Vyse TJ, Rioux JD (2006) Genetic variation in toll-like receptor 9 and susceptibility to systemic lupus erythematosus. Arthritis Rheum 54: 1279-1282.
40. Novak N, Yu CF, Bussmann C, Maintz L, Peng WM, et al. (2007) Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 62: 766-772.
41. Kim HM, Park BS, Kim JI, Kim SE, Lee J, et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906-917.
42. Choe J, Kelker MS, Wilson IA (2005) Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309: 581-585.
43. Chuang T, Ulevitch RJ (2001) Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 1518: 157-161.
44. Lazarus R, Raby BA, Lange C, Silverman EK, Kwiatkowski DJ, et al. (2004) TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples. Am J Respir Crit Care Med 170: 594-600.
45. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW (1988) Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318: 727-732.
46. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, et al. (2003) Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299: 2076-2079.
47. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, et al. (2006) Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314: 308-312.
48. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, et al. (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317: 1522-1527.
49. Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lan NT, et al. (2007) A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 37: 2280-2289.
50. Morris RW, Kaplan NL (2002) On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 23: 221-233.
51. Ma X, Liu Y, Gowen BB, Graviss EA, Clark AG, et al. (2007) Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One 2: e1318.
52. Misch EA, Hawn TR (2008) Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond) 114: 347-360.